Featured Research

from universities, journals, and other organizations

Dentistry: Resin infiltration effects in a caries-active environment -- two-year results

Date:
March 20, 2014
Source:
International & American Associations for Dental Research
Summary:
Researchers found in a pilot study that infiltration successfully stabilized early non-cavitated lesions in a small population with high caries-activity. Continuing follow-up may further confirm its efficacy. This pilot study identified important promising trends between the plaque and salivary metabolomes from caries-active and caries-free children, despite a relatively low number of subjects.

Today during the 43rd Annual Meeting & Exhibition of the American Association for Dental Research, held in conjunction with the 38th Annual Meeting of the Canadian Association for Dental Research, Mathilde C. Peters, University of Michigan, Ann Arbor, USA, will present research titled "Resin Infiltration Effects in a Caries-Active Environment -- 2 Year Results."

The objective of this study was to compare carious lesion changes after resin infiltration of approximal non-cavitated lesions in a high caries risk population after two years. Resin infiltration (I=Icon, DMG-Germany) was compared to mock infiltration (C=Control) in a split-mouth RCT. Lesion progression was monitored at two levels (lesion depth rating (E2/D1/D2) and lesion depth changes within ratings) in caries-active subjects (mean DMFT=7.4+2.0, age=14-36yrs), receiving standard-of-care preventive measures including F-supplementation.

After two years, 15 tooth pairs (68% recall) in 10 patients were available for analysis. Lesion depth rating and depth increase (within ratings) were visually determined from digital radiographs by two independent examiners (intra-/inter-evaluator agreement: k>0.70). Depth increase was confirmed by digital subtraction radiography (SDR). Ratings were statistically analyzed by logistic regression. Discrete time survival analysis (logistic regression and GEE modeling) was used to examine effects of treatment on probability of lesion increase over time, controlling for baseline severity.

The researchers found that infiltration successfully stabilized early non-cavitated lesions in a small population with high caries-activity. Continuing follow-up may further confirm its efficacy.

This pilot study identified important promising trends between the plaque and salivary metabolomes from caries-active and caries-free children, despite a relatively low number of subjects.


Story Source:

The above story is based on materials provided by International & American Associations for Dental Research. Note: Materials may be edited for content and length.


Cite This Page:

International & American Associations for Dental Research. "Dentistry: Resin infiltration effects in a caries-active environment -- two-year results." ScienceDaily. ScienceDaily, 20 March 2014. <www.sciencedaily.com/releases/2014/03/140320111905.htm>.
International & American Associations for Dental Research. (2014, March 20). Dentistry: Resin infiltration effects in a caries-active environment -- two-year results. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/03/140320111905.htm
International & American Associations for Dental Research. "Dentistry: Resin infiltration effects in a caries-active environment -- two-year results." ScienceDaily. www.sciencedaily.com/releases/2014/03/140320111905.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com
$23.6 Billion Awarded To Widow In Smoking Lawsuit

$23.6 Billion Awarded To Widow In Smoking Lawsuit

Newsy (July 20, 2014) Cynthia Robinson claims R.J. Reynolds Tobacco Company hid the health and addiction risks of its products, leading to the death of her husband in 1996. Video provided by Newsy
Powered by NewsLook.com
Tooth Plaque Provides Insight Into Diets Of Ancient People

Tooth Plaque Provides Insight Into Diets Of Ancient People

Newsy (July 19, 2014) Research on plaque from ancient teeth shows that our prehistoric ancestor's had a detailed understanding of plants long before developing agriculture. Video provided by Newsy
Powered by NewsLook.com
Contaminated Water Kills 3 Babies in South African Town

Contaminated Water Kills 3 Babies in South African Town

AFP (July 18, 2014) Contaminated water in South Africa's northwestern town of Bloemhof kills three babies and hospitalises over 500 people. The incident highlights growing fears over water safety in South Africa. Duration: 02:22 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins